Literature DB >> 7561950

Increased cathepsin B activity in multiple sclerosis brain.

C T Bever1, D W Garver.   

Abstract

Cathepsin B (CB) activity was measured in aqueous extracts of frozen autopsy specimens of centrum semiovale from three MS patients, five control patients with other neurological diseases, and five normal individuals. Mean activity was significantly increased in the MS tissue compared with controls. The mean activity in MS tissue containing demyelinating lesions was higher than that in normal appearing white matter which was higher than that in normal control specimens but the differences were not statistically significant. The mean CB activity in patients with other neurological diseases was higher than normal control activity and, although the difference was not statistically significant, this observation suggests that increases in CB may not be specific for MS. Immunohistochemical studies of the MS brain tissue analyzed biochemically suggested that monocytes, macrophages and reactive astrocytes are potential sources of increased CB in MS brain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561950     DOI: 10.1016/0022-510x(95)00039-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

1.  Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord.

Authors:  Tong Liu; K Christian Donahue; Jun Hu; Michael P Kurnellas; Jennifer E Grant; Hong Li; Stella Elkabes
Journal:  J Proteome Res       Date:  2007-06-16       Impact factor: 4.466

Review 2.  The multiple sclerosis degradome: enzymatic cascades in development and progression of central nervous system inflammatory disease.

Authors:  I A Scarisbrick
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

3.  Analysis of gene expression in MOG-induced experimental autoimmune encephalomyelitis after treatment with a novel brain-penetrating antioxidant.

Authors:  Yossi Gilgun-Sherki; Yael Barhum; Daphne Atlas; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

4.  Induced expression of cathepsins and cystatin C in a murine model of demyelination.

Authors:  Jianmei Ma; Kenji F Tanaka; Gen Yamada; Kazuhiro Ikenaka
Journal:  Neurochem Res       Date:  2006-11-04       Impact factor: 3.996

Review 5.  Cystatin C in aging and in Alzheimer's disease.

Authors:  Paul M Mathews; Efrat Levy
Journal:  Ageing Res Rev       Date:  2016-06-19       Impact factor: 10.895

Review 6.  The role of interferon-β in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis - in the perspective of inflammasomes.

Authors:  Makoto Inoue; Mari L Shinohara
Journal:  Immunology       Date:  2013-05       Impact factor: 7.397

7.  Theoretical insight into the mechanism for the inhibition of the cysteine protease cathepsin B by 1,2,4-thiadiazole derivatives.

Authors:  Mauricio Angel Vega-Teijido; Sarah El Chamy Maluf; Camila Ramalho Bonturi; Julio Ricardo Sambrano; Oscar N Ventura
Journal:  J Mol Model       Date:  2014-06-01       Impact factor: 1.810

Review 8.  Protective mechanisms by cystatin C in neurodegenerative diseases.

Authors:  Sebastien Gauthier; Gurjinder Kaur; Weiqian Mi; Belen Tizon; Efrat Levy
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

9.  NLRP3 Inflammasome and MS/EAE.

Authors:  Makoto Inoue; Mari L Shinohara
Journal:  Autoimmune Dis       Date:  2013-01-08

10.  Proteolytic characteristics of cathepsin D related to the recognition and cleavage of its target proteins.

Authors:  Huiying Sun; Xiaomin Lou; Qiang Shan; Ju Zhang; Xu Zhu; Jia Zhang; Yang Wang; Yingying Xie; Ningzhi Xu; Siqi Liu
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.